Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Ozempic, Rybelsus) and chronic weight management (Wegovy)
However, oral semaglutide (Rybelsus) can increase exposure to levothyroxine, requiring appropriate monitoring and timing
Lymphomas (Hodgkin and non-Hodgkin), leukemias, and metastatic solid tumors can present with lymph node enlargement
Increasing heart rate Worsening depression, behavior changes, or suicidality Never share the Wegovy pen with other people SIDE EFFECTS Many people experience no side effects
Whether youre in Uptown, South End, or surrounding areas, accessing the best place to buy tirzepatide is simple and convenient